117 related articles for article (PubMed ID: 37622629)
1. Glycyrrhizin Enhances the Proliferation of Diabetic Bone Marrow-derived Mesenchymal Stem Cells: A Potential Therapeutic Agent in Endodontic Surgery.
Gomaa MA; Elhawary YM; Badr AE
J Contemp Dent Pract; 2023 Jul; 24(7):494-499. PubMed ID: 37622629
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Glycyrrhizin on the Viability and Proliferation of Dental Pulp Stem Cells Compared to Intracanal Medicaments.
Alrashidi MA; Badawi MF; Elbeltagy MG; Badr AE
J Contemp Dent Pract; 2024 Mar; 25(3):267-275. PubMed ID: 38690701
[TBL] [Abstract][Full Text] [Related]
3. Photobiomodulation with 630 plus 810 nm wavelengths induce more in vitro cell viability of human adipose stem cells than human bone marrow-derived stem cells.
Zare F; Moradi A; Fallahnezhad S; Ghoreishi SK; Amini A; Chien S; Bayat M
J Photochem Photobiol B; 2019 Dec; 201():111658. PubMed ID: 31710923
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia modulates cell migration and proliferation in placenta-derived mesenchymal stem cells.
Li L; Jaiswal PK; Makhoul G; Jurakhan R; Selvasandran K; Ridwan K; Cecere R
J Thorac Cardiovasc Surg; 2017 Aug; 154(2):543-552.e3. PubMed ID: 28526501
[TBL] [Abstract][Full Text] [Related]
5. The red-light emitting diode irradiation increases proliferation of human bone marrow mesenchymal stem cells preserving their immunophenotype.
Lewandowski RB; Stępińska M; Gietka A; Dobrzyńska M; Łapiński MP; Trafny EA
Int J Radiat Biol; 2021; 97(4):553-563. PubMed ID: 33471577
[TBL] [Abstract][Full Text] [Related]
6. Electromagnetic fields and nanomagnetic particles increase the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells.
Kim MO; Jung H; Kim SC; Park JK; Seo YK
Int J Mol Med; 2015 Jan; 35(1):153-60. PubMed ID: 25352086
[TBL] [Abstract][Full Text] [Related]
7. Combined effects of low-level laser therapy and human bone marrow mesenchymal stem cell conditioned medium on viability of human dermal fibroblasts cultured in a high-glucose medium.
Hendudari F; Piryaei A; Hassani SN; Darbandi H; Bayat M
Lasers Med Sci; 2016 May; 31(4):749-57. PubMed ID: 26984346
[TBL] [Abstract][Full Text] [Related]
8. Role of mesenchymal stromal cells derivatives in diabetic foot ulcers: a controlled randomized phase 1/2 clinical trial.
Arango-Rodríguez ML; Solarte-David VA; Becerra-Bayona SM; Callegari E; Paez MD; Sossa CL; Vera MEO; Mateus LC; Eduardo Serrano S; Ardila-Roa AK; Viviescas LTG
Cytotherapy; 2022 Oct; 24(10):1035-1048. PubMed ID: 36084965
[TBL] [Abstract][Full Text] [Related]
9. Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice.
Hou Y; Ryu CH; Park KY; Kim SM; Jeong CH; Jeun SS
Stem Cell Res Ther; 2013 Jul; 4(4):77. PubMed ID: 23826999
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of novel clinical grade neonatal porcine bone marrow-derived mesenchymal stem cells.
Nishimura M; Nguyen L; Watanabe N; Fujita Y; Sawamoto O; Matsumoto S
Xenotransplantation; 2019 May; 26(3):e12501. PubMed ID: 30768802
[TBL] [Abstract][Full Text] [Related]
11. [Effects of 1,4-benzoquinone on the proliferation activity of human bone marrow stem cells].
Xiao Y; Ju L; Wu W; Gao XL; Wang J; Zhang X
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2012 May; 30(5):343-7. PubMed ID: 22804986
[TBL] [Abstract][Full Text] [Related]
12. Effect of inorganic phosphate on migration and osteogenic differentiation of bone marrow mesenchymal stem cells.
Lin H; Zhou Y; Lei Q; Lin D; Chen J; Wu C
BMC Dev Biol; 2021 Jan; 21(1):1. PubMed ID: 33407089
[TBL] [Abstract][Full Text] [Related]
13. The impact of diabetic glucose concentration on viability and cardiac differentiation of mesenchymal stem cells.
Nosrati S; Gheisari M; Zare S; Dara M; Zolghadri S; Razeghian-Jahromi I
Tissue Cell; 2024 Jun; 88():102361. PubMed ID: 38502970
[TBL] [Abstract][Full Text] [Related]
14. LIGHT (TNFSF14) enhances osteogenesis of human bone marrow-derived mesenchymal stem cells.
Heo SK; Choi Y; Jeong YK; Ju LJ; Yu HM; Kim DK; Seo HJ; Lee YJ; Cheon J; Koh S; Min YJ; Noh EK; Jo JC
PLoS One; 2021; 16(2):e0247368. PubMed ID: 33606781
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow - mesenchymal stem cells impact on the U937 cells in the presence of staphylococcal enterotoxin B (SEB).
Ejtehadifar M; Halabian R; Ghazavi A; Khansarinejad B; Mosayebi G; Imani Fooladi AA
Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):849-858. PubMed ID: 29655181
[TBL] [Abstract][Full Text] [Related]
16. Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes.
Shin L; Peterson DA
Stem Cells Transl Med; 2012 Feb; 1(2):125-35. PubMed ID: 23197759
[TBL] [Abstract][Full Text] [Related]
17. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D
Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696
[TBL] [Abstract][Full Text] [Related]
18. Silica-Coated Magnetic Nanoparticles Decrease Human Bone Marrow-Derived Mesenchymal Stem Cell Migratory Activity by Reducing Membrane Fluidity and Impairing Focal Adhesion.
Shin TH; Lee DY; Ketebo AA; Lee S; Manavalan B; Basith S; Ahn C; Kang SH; Park S; Lee G
Nanomaterials (Basel); 2019 Oct; 9(10):. PubMed ID: 31627375
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Porcine Versus Human Mesenchymal Stromal Cells From Three Distinct Donor Locations for Cytotherapy.
Schweizer R; Waldner M; Oksuz S; Zhang W; Komatsu C; Plock JA; Gorantla VS; Solari MG; Kokai L; Marra KG; Rubin JP
Front Immunol; 2020; 11():826. PubMed ID: 32435248
[No Abstract] [Full Text] [Related]
20. Triple-modal imaging of stem-cells labeled with multimodal nanoparticles, applied in a stroke model.
da Silva HR; Mamani JB; Nucci MP; Nucci LP; Kondo AT; Fantacini DMC; de Souza LEB; Picanço-Castro V; Covas DT; Kutner JM; de Oliveira FA; Hamerschlak N; Gamarra LF
World J Stem Cells; 2019 Feb; 11(2):100-123. PubMed ID: 30842808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]